Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Urinary bladder neoplasms | D001749 | — | C67 | 1 | — | — | — | — | 1 |
Transitional cell carcinoma | D002295 | — | — | 1 | — | — | — | — | 1 |
Drug common name | VOFATAMAB |
INN | vofatamab |
Description | Vofatamab is an antibody pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4297848 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | JMH6YR91PG (ChemIDplus, GSRS) |